Top Anti Cancer Imported Medicine Drugs in India - Pharama Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Beleodaq (Belinostat) Medicine in India

Beleodaq (Belinostat)

Medicine name : Beleodaq

Generic name : Belinostat

Manufactured By : Acrotech Bio Pharma Llc

Indications : Relapsed or Refractory Peripheral T-Cell Lymphoma

Medicine Description : Beleodaq is a histone deacetylase (HDAC) inhibitor used for relapsed/refractory peripheral T-cell lymphoma (PTCL). It modifies gene expression, inducing cancer cell death. Administered via IV, it is generally well-tolerated. Side effects include nausea, fatigue, fever, and anemia. Patients require blood count monitoring to manage potential toxicities.

Product Introduction

Beleodaq (Belinostat) is an anticancer medicine used to treat adults with relapsed or refractory peripheral T-cell lymphoma (PTCL). It belongs to a group of medicines known as histone deacetylase (HDAC) inhibitors. Belinostat works by blocking HDAC proteins involved in cancer cell growth and survival, helping to slow the progression of lymphoma. Beleodaq (Belinostat) is administered by a healthcare professional through an intravenous infusion. The dosage and treatment schedule are determined by your doctor based on your condition and response to treatment. Regular medical check-ups and blood tests may be required to monitor your response to therapy and detect potential side effects.

Common side effects of Beleodaq (Belinostat) may include nausea, fatigue, fever, vomiting, constipation, diarrhea, difficulty breathing, rash, swelling of the arms or legs, and reduced red blood cell counts. Some patients may also experience cough, chills, headache, itching, reduced appetite, or discomfort at the infusion site. Inform your doctor if any side effect becomes severe or persistent.

Before starting treatment with Beleodaq (Belinostat), inform your doctor about your medical history and all medicines, vitamins, herbal products, or supplements you are taking. Your doctor may regularly monitor your blood cell counts and liver function during treatment. Contact your doctor immediately if you develop signs of infection, unusual bleeding or bruising, severe tiredness, yellowing of the skin or eyes, or other concerning symptoms. Beleodaq (Belinostat) may harm an unborn baby, so women who can become pregnant should use effective contraception during treatment and for the recommended period after the final dose.

Uses Of Beleodaq (Belinostat)

Treatment of Peripheral T-cell Lymphoma

Benefits Of Beleodaq

Beleodaq (Belinostat) is used to treat relapsed or refractory peripheral T-cell lymphoma (PTCL) in adults. It works by inhibiting histone deacetylase (HDAC) proteins that are involved in the growth and survival of abnormal lymphoma cells. By blocking these signals, Belinostat helps slow the growth of cancer cells and may help control the progression of the disease.

Side Effects Of Beleodaq (Belinostat)

Some side effects of Beleodaq (Belinostat) may improve as your body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Beleodaq (Belinostat)

  • Low red blood cell count
  • Constipation
  • Diarrhea
  • Difficulty breathing
  • Skin rash
  • Swelling of the arms or legs
  • Itching
  • Headache
  • Loss of appetite
  • Muscle pain
How To Use Beleodaq

Beleodaq (Belinostat) is given by a healthcare professional as an intravenous infusion. The dose and treatment schedule are decided by your doctor based on your condition and response to treatment. It is usually administered once daily for the first 5 days of a treatment cycle. Do not self-administer or change the treatment schedule without medical advice.

How Beleodaq (Belinostat) Works

Beleodaq (Belinostat) works by blocking enzymes called histone deacetylases (HDACs), which help regulate the growth and survival of cells. By inhibiting these enzymes, Belinostat interferes with the growth and multiplication of abnormal lymphoma cells, helping to slow the progression of peripheral T-cell lymphoma (PTCL).

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Beleodaq (Belinostat).

PregnancyCONSULT YOUR DOCTOR

Beleodaq (Belinostat) may harm an unborn baby. Women who can become pregnant should use effective contraception during treatment and for 6 months after the last dose.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment with Beleodaq (Belinostat) and for 2 weeks after the final dose. Consult your doctor for guidance.

DrivingCONSULT YOUR DOCTOR

Beleodaq (Belinostat) may cause fatigue, dizziness, or other effects that can affect your ability to drive. Avoid driving if you experience these symptoms.

KidneyCAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor will determine if any additional monitoring or treatment adjustment is required.

LiverCAUTION

Tell your doctor if you have liver problems. Liver function may be monitored during treatment, and your doctor may adjust or pause treatment if necessary.

Quick Tips
  • Beleodaq (Belinostat) should be administered only by a healthcare professional according to your prescribed treatment schedule.
  • Attend regular blood tests so your doctor can monitor blood cell counts, liver function, and your response to treatment.
  • Contact your doctor immediately if you develop fever, chills, unusual bleeding or bruising, or signs of infection.
  • Drink plenty of fluids and inform your doctor if nausea, vomiting, or diarrhea becomes severe or does not improve.
  • Tell your doctor about all medicines, vitamins, herbal products, and supplements you are taking before starting treatment.
  • Read More About - Beleodaq (Belinostat) from Pharma Five.
Faq

General Question

Beleodaq (Belinostat) is a prescription anticancer medication used to treat relapsed or refractory peripheral T-cell lymphoma (PTCL), a rare and aggressive type of non-Hodgkin lymphoma.

Beleodaq is a histone deacetylase (HDAC) inhibitor. It works by altering gene expression in cancer cells, which can slow down or stop their growth and lead to cancer cell death.

Beleodaq is prescribed to adults diagnosed with PTCL who have not responded to or have relapsed after other treatments.

Beleodaq is given as an intravenous (IV) infusion by a healthcare professional, typically once daily for 5 days in a 21-day cycle.

Common side effects include nausea, fatigue, vomiting, fever, anemia, and low blood cell counts.

Yes, Beleodaq may cause serious side effects such as infections, liver problems, and bleeding. Contact your doctor if you experience symptoms like yellowing of the skin, unusual bruising, or high fever.

Treatment with Beleodaq continues as long as it is effective and well-tolerated. Your doctor will determine the appropriate duration based on your condition and response.

It’s best to avoid alcohol while on Beleodaq, as it may worsen side effects and increase the risk of liver problems.

No, Beleodaq may harm an unborn baby. Women should use effective contraception during treatment and for some time after the last dose.

Yes, Beleodaq can interact with other drugs, especially those affecting the liver. Inform your doctor of all medications, supplements, and herbal products you’re taking.

Since Beleodaq is given in a clinic or hospital, your healthcare provider will manage any missed doses or rescheduling.

Beleodaq is not taken orally; it is administered intravenously, so food intake does not affect its administration.

Avoid close contact with people who are sick, and report any signs of infection or unusual bleeding to your doctor. Routine blood tests are necessary to monitor your health during treatment.

Beleodaq is stored and handled by healthcare professionals. Patients are not responsible for home storage.

Beleodaq is available at hospitals and oncology clinics under prescription and administered by medical professionals. Speak with your oncologist for treatment scheduling. Pharma Five assists in its procurement.